SHELLEY WINZELER: Open Payments
NPI 1619081171 · HOMEWOOD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,622 in 77 payments from 22 companies in 2025. Trend: 2023 $1,597 · 2024 $1,791 · 2025 $1,622
Food & beverage: $1,622
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $317 |
| Arcutis Biotherapeutics, Inc. | 10 | $174 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $171 |
| GENZYME CORPORATION | 1 | $120 |
| KYOWA KIRIN, INC. | 4 | $103 |
| UCB, Inc. | 4 | $87 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Incyte Corporation | 4 | $60 |
| LEO Pharma Inc. | 2 | $52 |
Products named: Zoryve, COSENTYX, Winlevi, DUPIXENT, POTELIGEO, Bimzelx, Sotyktu, OPZELURA.
Industry payments across AL — which companies pay providers there.
